期刊文献+

2012年292例化学药品说明书样稿问题分析 被引量:4

Problem analysis of 292 cases of chemical drug labeling drafts in 2012
原文传递
导出
摘要 收集2012年审核的注册报送的化学药品说明书样稿292例,分析其中存在的不符合我国法规要求的问题,对问题较多的医学项目逐项详细列举其存在的主要问题和具体品种。结果发现样稿普遍存在问题,很难找到一份完全符合法规要求的样稿,问题较多的医学项目包括警示语、药理毒理、用法用量、不良反应、药代动力学、注意事项和药物过量等。这种现状应引起说明书撰写者足够重视。注意提高药品说明书质量,保证终端用户安全有效用药。 This paper collected 292 cases of chemical drug labeling drafts submitted for the registration and audited in 2012,and analyzed the problems thereof not meeting the requirements of laws and regulations of China.There are problems universally in the drug labeling drafts and it is very difficult to find one to conform to the laws and regulations request completely.More problems of medicinal sections include warning,pharmacology and toxicology,dosage and administration,adverse reactions,pharmacokinetics,and overdosage.This situation should arouse the enough attention of drafters for drug labeling.Pay attention to improve the specification of drug labeling and to ensure the safe and effective medication of the end users.
作者 萧惠来
出处 《现代药物与临床》 CAS 2013年第5期796-799,共4页 Drugs & Clinic
关键词 化学药品 药品说明书 样稿 问题 分析 chemical drugs drug labeling problem analysis
  • 相关文献

参考文献6

  • 1国家食品药品监督管理局.化学药品和治疗用生物制品说明书规范细则[EB/OL].http://www.sfda.gov.cn/WS01/CL0055/10528.html.2006-05-10.
  • 2FDA. Guidance for industry microbiological data for systemic antibacterial drug products -- Development, analysis, and presentation (draft) [EB/OL]. (2009-09-17). http://www, fda.gov/downloads/Drugs/GuidanceComplian ceRegulatorylnformation/Guidances/UCM 182288.pdf.
  • 3FDA. Guidance for industry developing antimicrobial drugs -- General considerations for clinical trials (draft) [EB/OL]. (1998-07-22). http://www, fdagov/downloads/ Drugs/GuidanceComplianceRegulatorylnformation/Guida nces/UCM070983.pdf.
  • 4Bristol-Myers Squibb Company. The prescribing information for AZACTAM (aztreonam for injection, USP) [EB/OL]. (2008-01-22). http://www.accessdata.fda. gov/drugsat fda_docs/label/2008/050580s040,050632s013 lbl.pdf.
  • 5Bayer hlthcare Company. The prescribing information for Nexavar (sorafenib) tablets [EB/OL]. (2011-10-14). http ://118.26.57.14:81 / 1Q2W3 E4R5 T6Y7U819OOP 1Z2X 3C4V5B/www.accessdata.fda.gov/drugsatfda_docs/label/ 2011/021923s0121bl.pdf.
  • 6Sanofi Aventis US Company. The prescribing information for Ambien (zolpidem tartrate) tablets [EB/OL]. (2010-04-14). http://www.accessdata.fda.gov/drugsatfda_ docs/label/2010/019908s0291bl.pdf.

共引文献7

同被引文献7

引证文献4

二级引证文献19

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部